Stockscreener 앱 받기
6.135
2.42%
0.145
시간 외 거래:
6.14
0.005
+0.08%
전일 마감가:
$5.99
열려 있는:
$5.96
하루 거래량:
82,752
Relative Volume:
0.38
시가총액:
$220.59M
수익:
$135.28M
순이익/손실:
$-99.56M
주가수익비율:
-1.8479
EPS:
-3.32
순현금흐름:
$-38.92M
1주 성능:
+7.07%
1개월 성능:
+14.03%
6개월 성능:
-3.99%
1년 성능:
-15.15%
1일 변동 폭
$5.944
$6.16
1주일 범위
$5.56
$6.16
52주 변동 폭
$3.6793
$8.90
Lifecore Biomedical Inc Stock (LFCR) Company Profile
명칭
Lifecore Biomedical Inc
전화
(952) 368-4300
주소
3515 LYMAN BOULEVARD, CHASKA
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-20 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations - GlobeNewswire
Lifecore Biomedical Makes Leadership Appointments - Contract Pharma
How To Trade (LFCR) - Stock Traders Daily
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer - Benzinga
Hyaluronic Acid (HA) Raw Material Market Size And Forecast -Salix Pharmaceuticals, ALLERGAN, Lifecore Biomedical, LLC, S – IndiaPolitics.com - IndiaPolitics.com
Johnson Fistel LLP Investigates Lifecore Biomedical, Inc’s - GlobeNewswire
Q3 2025 Earnings Forecast for Lifecore Biomedical, Inc. Issued By Barrington Research (NASDAQ:LFCR) - MarketBeat
Brokers Set Expectations for Lifecore Biomedical, Inc.'s Q1 2026 Earnings (NASDAQ:LFCR) - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock By Investing.com - Investing.com South Africa
Legion Partners Asset Management, LLC Increases Stake in Lifecore Biomedical Inc - GuruFocus.com
Wynnefield Partners Small Cap Acquires 122,930 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) Stock - MarketBeat
Wynnefield entities buy $1.2m of Lifecore Biomedical stock - Investing.com
Lifecore Biomedical stock price target increased on growth prospects By Investing.com - Investing.com UK
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results By Investing.com - Investing.com Australia
Earnings call: Lifecore Biomedical reports fiscal Q1 2025 results - Investing.com India
Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ... By GuruFocus - Investing.com Canada
Q1 2025 Lifecore Biomedical Inc Earnings Call Transcript - Stockxpo
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Marshall Wace LLP - MarketBeat
exhibit991-lfcrq1fy25ear.htm - SEC.gov
Lifecore Biomedical: Fiscal Q1 Earnings Snapshot - mySA
Lifecore Biomedical completes $24.3M private stock sale - Investing.com
Lifecore Biomedical completes $24.3M private stock sale By Investing.com - Investing.com Australia
Lifecore Raises Millions in Common Stock - Baystreet.ca
Lifecore Biomedical Raises $24.3M, Expands Capacity and Clientele - TipRanks
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Lifecore Biomedical, Inc. Reports Earnings Results for the First Quarter Ended August 25, 2024 - Marketscreener.com
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock - The Manila Times
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024 - The Manila Times
Lifecore secures $5M deal with Lindy Biosciences for CDMO services By Investing.com - Investing.com South Africa
Lifecore secures $5M deal with Lindy Biosciences for CDMO services - Investing.com Australia
Lindy Biosciences, Lifecore Biomedical Enter Multi-Million Dollar Development Agreement - Contract Pharma
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for - EIN News
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology - GlobeNewswire
FINAL DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore - AccessWire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
LFCR DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR) - Business Wire
Lifecore Biomedical Inc (LFCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.88%
0.42%
자본화:
|
볼륨(24시간):